Pliant Therapeutics, Inc. (PLRX)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Dec 26, 16:00
1.205
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics EPS Diluted (Quarterly): -0.4283 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Align Technology, Inc. | 0.7837 |
| Cidara Therapeutics, Inc. | -3.096 |
| Zymeworks, Inc. | -0.2587 |
| Bristol Myers Squibb Co. | 1.079 |
| Doximity, Inc. | 0.3091 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.30M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | -107.59M |
| Earnings Yield | -237.0% |
| Normalized Earnings Yield | -237.14 |